Tranexamic acid is a synthetic derivative of the amino acid lysine. It acts as an antifibrinolytic agent by inhibiting the conversion of plasminogen to plasmin, thereby preventing the breakdown of fibrin clots. This mechanism makes TXA effective in controlling bleeding.
